Infertility treatment financing in Nigeria

E. Adewumi
{"title":"Infertility treatment financing in Nigeria","authors":"E. Adewumi","doi":"10.4103/njhs.njhs_28_16","DOIUrl":null,"url":null,"abstract":"Background: In Nigeria, infertility treatment using assisted reproductive technology (ART) is perceived as an inconsequential health issue not demanding any public health intervention. ART is largely carried out by private health-care providers in city centres at an unaffordable cost. Objective: The objective is to determine ways to reduce the cost of in vitro fertilisation (IVF) to increase access to treatment. Materials and Methods: Google, Google Scholar and PubMed searches identified scholarly papers published between 1997 and 2013. The keywords used were combinations of ART, infertility treatment in developing countries, family planning and infertility, increasing ART success rate, male factor in infertility, fertility care financing, health insurance and cost of fertility treatment. Results: Infertility is not perceived as a disease the way malaria or typhoid is treated as such by most Nigerian men, and ART is expensive. Most African culture blame infertility on women who have restricted financial access. The current focus of family planning is female gender centric and favours contraception alone. The Nigerian National Health Insurance Scheme (NHIS) has excluded any ART treatment completely. Conclusion: The high cost of IVF is the greatest barrier to ART access both in the developed and underdeveloped world. This is also the most critical factor in accessing IVF care worldwide. This financial barrier is worse in low-resource settings like Nigeria. Low-cost technological innovation is still far from the country. Recommendations: Renewed advocacy with focus on men to understand that infertility is a disease deserving of utmost attention. Increase in the number of public-funded fertility clinics and partial inclusion of IVF into the Nigerian National Health Insurance Scheme (NHIS) needs to be implemented to bring down cost. Other innovations such as public–private partnerships, where financial institutions like banks can finance IVF treatment by giving loans whose repayment is spread over time to make it convenient, should also be considered.","PeriodicalId":19310,"journal":{"name":"Nigerian Journal of Health and Biomedical Sciences","volume":"5 1","pages":"38 - 42"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nigerian Journal of Health and Biomedical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/njhs.njhs_28_16","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Background: In Nigeria, infertility treatment using assisted reproductive technology (ART) is perceived as an inconsequential health issue not demanding any public health intervention. ART is largely carried out by private health-care providers in city centres at an unaffordable cost. Objective: The objective is to determine ways to reduce the cost of in vitro fertilisation (IVF) to increase access to treatment. Materials and Methods: Google, Google Scholar and PubMed searches identified scholarly papers published between 1997 and 2013. The keywords used were combinations of ART, infertility treatment in developing countries, family planning and infertility, increasing ART success rate, male factor in infertility, fertility care financing, health insurance and cost of fertility treatment. Results: Infertility is not perceived as a disease the way malaria or typhoid is treated as such by most Nigerian men, and ART is expensive. Most African culture blame infertility on women who have restricted financial access. The current focus of family planning is female gender centric and favours contraception alone. The Nigerian National Health Insurance Scheme (NHIS) has excluded any ART treatment completely. Conclusion: The high cost of IVF is the greatest barrier to ART access both in the developed and underdeveloped world. This is also the most critical factor in accessing IVF care worldwide. This financial barrier is worse in low-resource settings like Nigeria. Low-cost technological innovation is still far from the country. Recommendations: Renewed advocacy with focus on men to understand that infertility is a disease deserving of utmost attention. Increase in the number of public-funded fertility clinics and partial inclusion of IVF into the Nigerian National Health Insurance Scheme (NHIS) needs to be implemented to bring down cost. Other innovations such as public–private partnerships, where financial institutions like banks can finance IVF treatment by giving loans whose repayment is spread over time to make it convenient, should also be considered.
尼日利亚的不孕症治疗融资
背景:在尼日利亚,使用辅助生殖技术治疗不孕症被认为是一个无关紧要的健康问题,不需要任何公共卫生干预。抗逆转录病毒治疗主要由城市中心的私人保健提供者提供,费用高得难以承受。目的:目的是确定降低体外受精(IVF)成本的方法,以增加获得治疗的机会。材料和方法:Google、Google Scholar和PubMed检索了1997年至2013年间发表的学术论文。使用的关键词是联合使用抗逆转录病毒治疗、发展中国家的不孕症治疗、计划生育和不孕症、提高抗逆转录病毒治疗成功率、不孕症中的男性因素、生育护理融资、健康保险和生育治疗费用。结果:在大多数尼日利亚男子看来,不孕症不像疟疾或伤寒那样被视为一种疾病,而且抗逆转录病毒治疗费用昂贵。大多数非洲文化将不孕归咎于经济拮据的妇女。目前计划生育的重点是以女性为中心,只提倡避孕。尼日利亚国家健康保险计划(NHIS)完全排除了任何抗逆转录病毒治疗。结论:无论是在发达国家还是在不发达国家,IVF的高费用都是获得ART的最大障碍。这也是在全球范围内获得试管婴儿护理的最关键因素。这种财政障碍在尼日利亚等资源匮乏的国家更为严重。低成本的技术创新离这个国家还很远。建议:重新开展以男性为重点的宣传,让他们了解不育症是一种值得高度关注的疾病。需要增加公共资助的生育诊所的数量,并将体外受精部分纳入尼日利亚国家健康保险计划,以降低成本。也应该考虑其他创新,如公私合作伙伴关系,即银行等金融机构可以通过提供贷款来资助试管婴儿治疗,这些贷款可以分期偿还,以方便试管婴儿治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信